James B. Tananbaum, Director, Ten Percent Owner at Latigo Biotherapeutics, Inc., holds 3.41M shares in Latigo Biotherapeutics, Inc. (Ticker: LTGO), holds 15.69M shares in Alumis Inc. (Ticker: ALMS), holds 0.00 shares in Kinnate Biopharma (Ticker: KNTE).
What is the percentage of profitable transactions made by James B. Tananbaum?
The percentage of profitable transactions made by James B. Tananbaum is 50%.
What is the average return per transaction made by James B. Tananbaum?
The average return per transaction made by James B. Tananbaum is 46.60%.
What stocks does James B. Tananbaum hold?
James B. Tananbaum holds: LTGO, KNTE, IRON, QSI, PRDS, ALMS stocks.
What was James B. Tananbaum’s latest transaction?
James B. Tananbaum latest transaction was an Uninformative Buy of ―.
What was James B. Tananbaum's most profitable transaction?
James B. Tananbaum’s most profitable transaction was an Informative Buy of ALMS stock on May 6, 2025. The return on the trade was 486.20%.
What is James B. Tananbaum's role in Latigo Biotherapeutics, Inc.?
James B. Tananbaum's role in Latigo Biotherapeutics, Inc. is Director, Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.